Includes index
Chiefly tables

Abbreviations
Table 1. Clinical approaches to initial choice of antimicrobial therapy
Table 2. Recommended antimicrobial agents against selected bacteria
Table 3. Suggested duration of antibiotic therapy for selected clinical syndromes in immunocompetent patients
Table 4A. Antibacterial activity spectra
Table 4B. Antifungal activity spectra
Table 4C. Antiviral activity spectra
Table 5A. Treatment options for systemic infection due to multi-drug resistant gram-positive bacteria
Table 5B. Treatment options for systemic infection due to culture-identified multi-drug resistant gram-negative bacilli
Table 6. Suggested management of suspected or culture-positive methicillin-resistant S. aureus infections
Table 7. Antibiotic hypersensitivity reactions & drug desensitization methods
Table 8. Pregnancy risk and safety in lactation
Table 9A. Selected pharmacologic features of antimicrobial agents
Table 9B. Pharmacodynamics of antibacterials
Table 9C. Enzyme- and transporter- mediated interactions of antimicrobials
Table 10A. Antibiotic dosage and side-effects
Table 10B. Antimicrobial agents associated with photosensitivity
Table 10C. Aminoglycoside once daily and multiple daily dosing regimens
Table 10D. Prolonged or continuous infusion dosing of selected antibodies
Table 10E. Inhalation antibiotics
Table 11A. Treatment of fungal infections
Table 11B. Antifungal drugs : Dosage, adverse effects, comments
Table 12A. Treatment of mycobacterial infections
Table 12B. Dosage and adverse effects of antimycobacterial drugs
Table 13A. Treatment of parasitic infections
Table 13B. Dosage and selected adverse effects of antiparasitic drugs
Table 13C. Parasites that cause Eosinophilia (Eosinophilia in travelers)
Table 13D. Sources for hard-to-find antiparasitic drugs
Table 14A. Antiviral therapy
Table 14B. Antiviral drugs (Non-HIV)
Table 14C. Antiretroviral Therapy (ART) in treatment-naïve adults (HIV/AIDS)
Table 14D. Antiretroviral drugs and adverse effects
Table 14E. Hepatitis A & HBV treatment
Table 14F. HCV treatment regimens and response
Table 15A. Antimicrobial prophylaxis for selected bacterial infections
Table 15B. Antibiotic prophylaxis to prevent surgical infections in adults
Table 15C. Antimicrobial prophylaxis for the prevention of bacterial endocarditis in patients with underlying cardiac conditions
Table 15D. Management of exposure to HIV-1 and Hepatitis B and C
Table 15E. Prevention of selected opportunistic infections in Human Hematopoietic Cell Transplantation (HCT) or Solid Organ Transplantation (SOT) in adults with normal renal function
Table 16. Pediatric dosing (Age >28 days)
Table 17A. Dosage of antimicrobial drugs in adult patients with renal impairment
Table 17B. No dosage adjustment wit renal insufficiency by category
Table 17C. Antimicrobial dosing in obesity
Table 17D. No dosing adjustments required in obesity
Table 18. Antimicrobials and hepatic disease : Dosage adjustment
Table 19. Treatment of CAPD peritonitis in adults
Table 20A. Anti-tetanus prophylaxis, wound classification, immunization
Table 20B. Rabies postexposure prophylaxis
Table 21. Selected directory of resources
Table 22A. Anti-infective drug-drug interactions
Table 22B. Drug-drug interactions between Non-nucleoside Reverse Transcriptase inhibitors (NNRTIS) and protease inhibitors
Table 23. List of generic and trade names
Index

"This 50th edition of the Sanford Guide to Antimicrobial Therapy continues to provide accessible, concise, evidence-based guidance for appropriate treatment of infectious diseases. As drug resistance continues to narrow treatment options, antimicrobial stewardship only increases in importance."--taken from back of front cover